Physiologic Response to Non-Invasive Respiratory Support in Obese Patients with Acute Hypoxemic Respiratory Failure from COVID-19
Enrolling By Invitation
18 years - 99 years
All
Phase
N/A
15 participants needed
1 Location
Brief description of study
This research study only enrolls hospitalized patients at Penn Medicine.
The purpose of the study is to assess differences in respiratory and ventilation parameters between HFNC and helmet CPAP in obese patients with COVID-19 AHRF. We will enroll patients admitted to a HUP ICU with COVID-19 who have an obese BMI and are receiving HFNC. Patients will be monitored with electrical impedance tomography (EIT) in addition to standard ICU monitors. Patients will receive alternating treatment with HFNC and helmet CPAP over a 90 minute study period.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: COVID-19, ICU admitted, obese, low risk of intubation
-
Age: 18 years - 99 years
-
Gender: All
Updated on
04 Aug 2024.
Study ID: 844516
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
